Ridgetech, Inc. (RDGT) - Net Assets

Latest as of June 2026: $40.78 Million USD

Based on the latest financial reports, Ridgetech, Inc. (RDGT) has net assets worth $40.78 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($69.03 Million) and total liabilities ($28.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RDGT strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets $40.78 Million
% of Total Assets 59.07%
Annual Growth Rate 5.74%
5-Year Change 79.33%
10-Year Change 52.93%
Growth Volatility 51.3

Ridgetech, Inc. - Net Assets Trend (2010–2026)

This chart illustrates how Ridgetech, Inc.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see RDGT company net worth.

Annual Net Assets for Ridgetech, Inc. (2010–2026)

The table below shows the annual net assets of Ridgetech, Inc. from 2010 to 2026. Also explore Ridgetech, Inc. equity growth rate to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2026-03-31 $40.78 Million +37.59%
2025-03-31 $29.64 Million +107.35%
2024-03-31 $14.29 Million -14.24%
2023-03-31 $16.67 Million -26.70%
2022-03-31 $22.74 Million -6.82%
2021-03-31 $24.40 Million +29.95%
2020-03-31 $18.78 Million +10.65%
2019-03-31 $16.97 Million -10.03%
2018-03-31 $18.86 Million -29.26%
2017-03-31 $26.66 Million +38.04%
2016-03-31 $19.32 Million +12.08%
2015-03-31 $17.23 Million +19.98%
2014-03-31 $14.36 Million -62.35%
2013-03-31 $38.15 Million -27.13%
2012-03-31 $52.35 Million +24.46%
2011-03-31 $42.06 Million +152.03%
2010-03-31 $16.69 Million --

Equity Component Analysis

This analysis shows how different components contribute to Ridgetech, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 6455946400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component Amount Percentage
Common Stock $133.09K 0.33%
Other Comprehensive Income $1.31 Million 3.21%
Other Components $103.90 Million 254.80%
Total Equity $40.78 Million 100.00%

Ridgetech, Inc. Competitors by Market Cap

The table below lists competitors of Ridgetech, Inc. ranked by their market capitalization.

Company Market Cap
EMPYREAN ENERGY LS-002
F:E1E
$3.34 Million
Archon Minerals Ltd
V:ACS
$3.35 Million
GRI Bio Inc.
NASDAQ:GRI
$3.35 Million
Immersion SA
PA:ALIMR
$3.35 Million
Niki BioSolutions, Inc.
NASDAQ:NIKI
$3.34 Million
REDSUN PROPERTIES GROUP
F:0RJ
$3.34 Million
Madhav Marbles and Granites Limited
NSE:MADHAV
$3.34 Million
PreveCeutical Medical Inc
F:18H
$3.34 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ridgetech, Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 29,636,382 to 40,776,638, a change of 11,140,256 (37.6%).
  • Net loss of 1,250,422 reduced equity.
  • New share issuances of 10,883,257 increased equity.
  • Other comprehensive income increased equity by 1,507,419.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income $-1.25 Million -3.07%
Share Issuances $10.88 Million +26.69%
Other Comprehensive Income $1.51 Million +3.7%
Other Changes $2.00 +0.0%
Total Change $- 37.59%

Book Value vs Market Value Analysis

This analysis compares Ridgetech, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.17x to 0.00x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-03-31 $5.55 $0.92 x
2008-03-31 $0.18 $0.92 x
2010-03-31 $8344874.50 $0.92 x
2011-03-31 $21031958.50 $0.92 x
2012-03-31 $17450799.33 $0.92 x
2013-03-31 $12716496.00 $0.92 x
2014-03-31 $4774483.00 $0.92 x
2015-03-31 $5731442.00 $0.92 x
2016-03-31 $6438624.00 $0.92 x
2017-03-31 $6666094.25 $0.92 x
2018-03-31 $3772481.00 $0.92 x
2019-03-31 $3633041.20 $0.92 x
2020-03-31 $3431822.33 $0.92 x
2021-03-31 $3217838.13 $0.92 x
2022-03-31 $3010674.13 $0.92 x
2023-03-31 $783217.87 $0.92 x
2024-03-31 $244375.16 $0.92 x
2025-03-31 $120473.10 $0.92 x
2026-03-31 $561.17 $0.92 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ridgetech, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.07%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -0.95%
  • • Asset Turnover: 1.91x
  • • Equity Multiplier: 1.69x
  • Recent ROE (-3.07%) is above the historical average (-116.74%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 -12.31% 0.00% 0.00x 1.00x $-6.77K
2008 -1790.04% 0.00% 0.00x 1.00x $-28.91K
2010 58.85% 17.80% 2.30x 1.44x $8.15 Million
2011 20.05% 12.05% 1.30x 1.28x $4.23 Million
2012 15.55% 8.63% 1.26x 1.43x $2.91 Million
2013 -37.57% -16.02% 1.32x 1.78x $-18.15 Million
2014 -177.03% -38.33% 1.44x 3.21x $-26.79 Million
2015 4.98% 1.11% 1.29x 3.46x $-862.88K
2016 2.31% 0.50% 1.43x 3.21x $-1.48 Million
2017 -21.17% -6.93% 1.21x 2.52x $-8.31 Million
2018 -90.44% -17.75% 1.30x 3.91x $-18.95 Million
2019 -5.10% -0.86% 1.48x 4.00x $-2.74 Million
2020 -28.23% -4.95% 1.18x 4.83x $-7.87 Million
2021 -31.54% -6.10% 1.25x 4.13x $-10.69 Million
2022 -13.25% -1.94% 1.55x 4.42x $-5.60 Million
2023 -117.34% -14.20% 1.64x 5.05x $-22.94 Million
2024 -27.07% -2.74% 1.63x 6.08x $-5.80 Million
2025 34.40% 8.50% 1.86x 2.18x $7.23 Million
2026 -3.07% -0.95% 1.91x 1.69x $-5.33 Million

Industry Comparison

This section compares Ridgetech, Inc.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $2,757,790,816
  • Average return on equity (ROE) among peers: -251.27%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ridgetech, Inc. (RDGT) $40.78 Million -12.31% 0.69x $3.34 Million
Bimi International Medical Inc (BIMI) $-178.41K 0.00% 0.00x $6.98K
High Tide Inc (HITI) $102.77 Million -49.38% 2.40x $204.80 Million
Trxade Group Inc (MEDS) $17.48K -862.05% 5.79x $8.12 Million
PetMed Express Inc (PETS) $1.63 Million -110.02% 2.88x $34.62 Million
POMDOCTOR LIMITED American Depositary Shares (POM) $-1.90 Billion 0.00% 0.00x $5.62 Million
Scienture Holdings, Inc. (SCNX) $342.87K -1012.67% 9.82x $13.92 Million
SunLink Health Systems Inc (SSY) $33.74 Million 13.30% 1.02x $7.85 Million
Walgreens Boots Alliance Inc (WBA) $23.82 Billion 10.67% 2.41x $10.37 Billion

About Ridgetech, Inc.

NASDAQ:RDGT USA Pharmaceutical Retailers
Market Cap
$3.67 Million
Market Cap Rank
#29288 Global
#5981 in USA
Share Price
$1.01
Change (1 day)
+23.77%
52-Week Range
$0.02 - $5.07
All Time High
$5.07
About

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, tra… Read more